Payments to Acquire Property, Plant, and Equipment of Travere Therapeutics, Inc. from 31 Mar 2012 to 31 Mar 2024

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Travere Therapeutics, Inc. quarterly and annual Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Mar 2012 to 31 Mar 2024.
  • Travere Therapeutics, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2024 was $0, a 100% decline year-over-year.
  • Travere Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $668,000, a 250% increase from 2022.
  • Travere Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2022 was $191,000, a 96% decline from 2021.
  • Travere Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2021 was $5,101,000, a 25% decline from 2020.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)

Travere Therapeutics, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $0 -$630,000 -100% 01 Jan 2024 31 Mar 2024 10-Q 06 May 2024 2024 Q1
Q1 2023 $630,000 +$499,000 +381% 01 Jan 2023 31 Mar 2023 10-Q 06 May 2024 2024 Q1
Q1 2022 $131,000 -$4,364,000 -97% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023 2023 Q1
Q1 2021 $4,495,000 +$4,287,000 +2061% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2022 Q1
Q1 2020 $208,000 +$189,000 +995% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021 2021 Q1
Q1 2019 $19,000 -$20,000 -51% 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020 2020 Q1
Q1 2018 $39,000 -$799,000 -95% 01 Jan 2018 31 Mar 2018 10-Q 07 May 2019 2019 Q1
Q1 2017 $838,000 +$814,000 +3392% 01 Jan 2017 31 Mar 2017 10-Q 06 Jul 2018 2018 Q1
Q1 2016 $24,000 -$1,000 -4% 01 Jan 2016 31 Mar 2016 10-Q 05 May 2017 2017 Q1
Q1 2015 $25,000 -$141,144 -85% 01 Jan 2015 31 Mar 2015 10-Q 05 May 2016 2016 Q1
Q1 2014 $166,144 +$159,302 +2328% 01 Jan 2014 31 Mar 2014 10-Q 11 May 2015 2015 Q1
Q1 2013 $6,842 +$4,334 +173% 01 Jan 2013 31 Mar 2013 10-Q 15 May 2014 2014 Q1
Q1 2012 $2,508 01 Jan 2012 31 Mar 2012 10-Q/A 16 Sep 2013 2013 Q1

Travere Therapeutics, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $668,000 +$477,000 +250% 01 Jan 2023 31 Dec 2023 10-K 20 Feb 2024 2023 FY
2022 $191,000 -$4,910,000 -96% 01 Jan 2022 31 Dec 2022 10-K 20 Feb 2024 2023 FY
2021 $5,101,000 -$1,666,000 -25% 01 Jan 2021 31 Dec 2021 10-K 20 Feb 2024 2023 FY
2020 $6,767,000 +$6,572,000 +3370% 01 Jan 2020 31 Dec 2020 10-K 23 Feb 2023 2022 FY
2019 $195,000 -$532,000 -73% 01 Jan 2019 31 Dec 2019 10-K 24 Feb 2022 2021 FY
2018 $727,000 -$160,000 -18% 01 Jan 2018 31 Dec 2018 10-K 01 Mar 2021 2020 FY
2017 $887,000 -$541,000 -38% 01 Jan 2017 31 Dec 2017 10-K 24 Feb 2020 2019 FY
2016 $1,428,000 +$1,406,000 +6391% 01 Jan 2016 31 Dec 2016 10-K 26 Feb 2019 2018 FY
2015 $22,000 -$641,000 -97% 01 Jan 2015 31 Dec 2015 10-K 06 Jul 2018 2017 FY
2014 $663,000 +$546,000 +467% 01 Jan 2014 31 Dec 2014 10-K 01 Mar 2017 2016 FY
2013 $117,000 +$92,226 +372% 01 Jan 2013 31 Dec 2013 10-K 26 Feb 2016 2015 FY
2012 $24,774 01 Jan 2012 31 Dec 2012 10-K/A 09 Jul 2015 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.